Stefan Laufer - Concepedia

Author

Stefan Laufer

Also Known As

Denny, R. Aldrin, Gillespie, Paul, Laufer, S., Laufer, S.A., Laufer, Shlomi, Laufer, Sonja, Laufer, Stefan, Laufer, Stefan A., Miao, Edward A., N. Burgess-Brown

815

Publications

20K

Citations

H-Index

241

Concepts

All Affiliations

University of Tübingen Merck (Germany)University Children's Hospital Tübingen Bernstein Center for Computational Neuroscience Tübingen Goethe University Frankfurt

About

Stefan Laufer is an author at University of Tübingen specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	142	7.7K
2	Engineering	15	18	826
3	Health Sciences	8	8	1.1K
4	Business	1	1	17
5	Education	1	1	46

Stefan Laufer

272

Publications

14.9K

Citations

H-Index

Page 1

	Year	Citations
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation Oliver Borst, Britta Walker, Patrick Münzer, Cellular Physiology and Biochemistry	2013	1.9K
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease Lutz Frölich, D. Blum‐Degen, Hans‐Gert Bernstein, Journal of Neural Transmission Insulin ReceptorsAlzheimer's DiseaseAgingBrain InsulinSporadic Alzheimer	1998	746
Determination of the wound healing effect of Calendula extracts using the scratch assay with 3T3 fibroblasts Márcio Fronza, Berta Maria Heinzmann, Matthias Hamburger, Journal of Ethnopharmacology MedicineCutaneous BiologyWound CareWound HealingScratch Assay	2009	356
Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord Sarah Taves, Temugin Berta, Da-Lu Liu, Brain Behavior and Immunity InflammationNeuroinflammationPain SyndromeSpinal Cord InjuryP38 Map Kinase	2015	314
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer Ramona Rudalska, Daniel Dauch, Thomas Longerich, Nature Medicine Tumor BiologySystems BiologyEngineeringMedicineLiver Physiology	2014	276
A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer Daniel Dauch, Ramona Rudalska, Giacomo Cossa, Nature Medicine Tumor BiologyMedicineReceptor Tyrosine KinaseCancer Cell BiologyTumor Suppressor	2016	263
Tetrasubstituted Imidazole Inhibitors of Cytokine Release: Probing Substituents in the N-1 Position Stefan Laufer, W Zimmermann, Kathrin J. Ruff Journal of Medicinal Chemistry	2004	171
Progress towards a public chemogenomic set for protein kinases and a call for contributions David H. Drewry, Carrow I. Wells, David Andrews, PLoS ONE Drug TargetPublic Chemogenomic SetMolecular BiologyTumor BiologyReceptor Tyrosine Kinase	2017	166
Licofelone Suppresses Prostaglandin E2 Formation by Interference with the Inducible Microsomal Prostaglandin E2 Synthase-1 Andreas Koeberle, Ulf Siemoneit, Ulrike Bühring, Journal of Pharmacology and Experimental Therapeutics	2008	163
IL‐1β, IL‐18, and eicosanoids promote neutrophil recruitment to pore‐induced intracellular traps following pyroptosis Ine Jørgensen, Joseph P Lopez, Stefan Laufer, European Journal of Immunology	2016	160

Page 1